sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > MAPK Signaling > JNK > DB07268
DB07268  
Catalog No. T3200    CAS 929007-72-7
Pack Size
Availability
Price/USD
Quantity
1mg
In stock
81.00
5mg
In stock
140.00
10mg
In stock
220.00
25mg
In stock
396.00
50mg
In stock
660.00
1 mL * 10 mM (in DMSO)
In stock
140.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:98.21% COA Datasheet HNMR HPLC MSDS
Biological Activity:

Product Description:

DB07268 is a potent and selective JNK1 inhibitor.

Target:
JNK1;
Research Area:
Cancer
Chemical Information:
Molecular Weight 321.33
Formula C17H15N5O2
CAS Number 929007-72-7
Solubility DMSO:≥32 mg/mL
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
Product Recommendations
  • Brequinar, Brequinar is a potent inhibitor of dihydroorotate dehydrogenase, with potent activities against a br...
  • Nimustine Hydrochloride, Nimustine has been used in trials studying the treatment of Glioblastoma.
  • ISOQUERCITRIN, Isoquercitrin is an effective antioxidant and an eosinophilic inflammation suppressor.
  • Avapritinib, Avapritinib is a dual inhibitor of the mutant KIT receptor (KIT D816V, IC50: 0.27 nM) and PDGFRα (PD...
  • LY3200882, LY3200882 is a highly selective inhibitor of TGF-β receptor type 1 (TGFβRI).

 

Reference

If you have additional questions, Please send us a message. * Required